Weekly high-dose paclitaxel in locally advanced and metastatic breast cancer: A BrUOG study

被引：0
|
作者：
Sikov, W
Akerley, W
Strenger, R
Cummings, F
Legare, R
Safran, H
Mega, A
机构：
[1] Miriam Hosp, Providence, RI 02906 USA
[2] Rhode Isl Hosp, Providence, RI USA
[3] Brown Univ, Women & Infants Hosp, Providence, RI USA
[4] Roger Williams Canc Med Ctr, Providence, RI USA
[5] Brown Univ, Oncol Grp, Providence, RI USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [41] Frequent pathologic complete responses seen with neoadjuvant q4week carboplatin and weekly paclitaxel ± weekly trastuzumab in resectable and locally advanced breast cancer: a Brown University Oncology Group (BrUOG) Study.
    Fenton, MA
    Ries, LM
    Strenger, R
    Dizon, DS
    Legare, RD
    Joseph, PJ
    Theall, KP
    Graves, TA
    Gass, JS
    Sikov, WM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S224 - S225
  • [42] Repetitive high-dose therapy with peripheral blood progenitor cell (PBPC) support for metastatic (MBC) and locally advanced breast cancer
    不详
    Bone Marrow Transplantation, 2000, 26 (Suppl 1) : S7 - S8
  • [43] DOSE-DENSE WEEKLY CARBOPLATIN AND PACLITAXEL AS NEOADJUVANT CHEMOTERAPY IN LOCALLY ADVANCED CERVICAL CANCER
    Crupano, F. M.
    Cormio, G.
    Loizzi, V.
    Del Vecchio, V.
    Fumarulo, V. V.
    Minicucci, V.
    Murgia, F.
    Grasso, S.
    Camporeale, A.
    Leone, L.
    Resta, L.
    Cicinelli, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 322 - 322
  • [44] HIGH-DOSE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
    LEONARD, RCF
    LANCET, 1994, 344 (8929): : 1084 - 1084
  • [45] Cisplatin-epirubicin-paclitaxel (PET) weekly administration vs. epirubicin-paclitaxel (ET) in locally advanced or metastatic breast cancer.
    Maiorino, LG
    Frasci, G
    D'Aiuto, G
    Comello, P
    Cartenì, P
    Thomas, R
    Capasso, I
    Cortino, GR
    DeCataldis, G
    Silvestro, L
    Russo, A
    Di Bonito, M
    Comella, G
    ANNALS OF ONCOLOGY, 2000, 11 : 45 - 45
  • [46] HIGH-DOSE WEEKLY FRACTIONATION RADIOTHERAPY IN ADVANCED CANCER OF THE UTERINE CERVIX
    BROWDE, S
    NISSENBAUM, M
    DEMOOR, NG
    SOUTH AFRICAN MEDICAL JOURNAL, 1984, 66 (01): : 11 - 14
  • [47] Up front tandem high-dose chemotherapy compared to standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: the International Randomized Breast Cancer Dose Intensity Study
    Crown, J
    Leyvraz, S
    Perey, L
    Verrill, M
    Guillem, V
    Efremidis, A
    Garcia-Conde, BJ
    Welch, R
    Montes, A
    Piazza, E
    Rappaport, B
    Pienkowski, T
    Skotnicki, A
    Cameron, D
    Vahdat, L
    Bobev, DG
    Bertelli, G
    Leonard, R
    Baselga, B
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S152 - S152
  • [48] Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity
    Nistico, Cecilia
    Bria, Emilio
    Vaccaro, Vanja
    Cuppone, Federica
    Fornier, Monica
    Sperduti, Isabella
    Carpino, Armando
    Izzo, Fiorentino
    Tropea, Francesco
    Cognetti, Francesco
    Terzoli, Edmondo
    ANTI-CANCER DRUGS, 2009, 20 (02) : 109 - 114
  • [49] A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
    Lin, Chia-Chi
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    Lu, Yen-Shen
    Hsu, Chiun
    Yeh, Kun-Huei
    Wu, Chen-Yao
    Huang, Chiun-Sheng
    Yang, Chih-Hsin
    ANTICANCER RESEARCH, 2007, 27 (1B) : 641 - 645
  • [50] Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer
    Greco, FA
    Hainsworth, JD
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 61 - 64
12345